Category: HCV

New Study: The Impact of the COVID-19 Health Crisis on Access to HIV Services in Egypt, Morocco, Mauritania, and Tunisia.

A study was carried out by the FORSS consortium which includes (ITPC-MENA, Solidarité SIDA, AGD, ATP+, Al Shehab RdR Maroc, and M-Coalition). This recently developed report analyzes the impact of the COVID-19 pandemic on HIV-related health services in the MENA...

/ 25 April 2023

GLOBAL SURVEY ON ACCESS TO AND QUALITY OF HIV CARE AND TREATMENT – LEBANON & MOROCCO (MENA)

The International Treatment Preparedness Coalition (ITPC) conducted its first Global HIV Treatment Access Survey in 2018 to assess the current state of HIV/AIDS care and treatment services in 14 countries and to document the challenges and barriers facing people living...

/ 27 January 2021

Call for application : MENA-CAB meeting 2018

Are you advocates of the right to health and access to treatment? or activist living with HIV, hepatitis C, hepatitis B or tuberculosis in the North Africa and Middle East (MENA) region? Would you like to participate in an interactive...

/ 12 September 2018

GSIPA2M streaming

PATHWAYS TO ACCESS 15-17 January 2018 MARRAKESH – MOROCCO Read More

/ 15 January 2018

New Study : Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)

Title: A tool to assess how friendly to access-to-medicines your law is Background Provisions of intellectual property (IP) may have an important impact on access to medicines. For instance, the monopoly granted by the patent prevents competition with generics on...

/ 26 October 2017

ITPC-MENA organize its Middle East and North Africa Community Advisory board (MENACAB)

The International Treatment Preparedness Coalition in Middle East and North Africa (ITPC-MENA) is organizing its Middle East and North Africa Community Advisory board (MENACAB), in late November in Marrakech.The MENACAB is a treatment advocate network which main aim is to improve...

/ 15 October 2017

ITPC-MENA at the Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017)

ITPC-MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) Join ITPC-MENA at AFRAMED 2017 – Hammamet Join ITPC_MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) in Tunis and Hammamet from 27 – 30 September 2017. We...

/ 21 September 2017

2nd Francophone Symposium AFRAMED on HIV and Hepatitis

2nd Francophone Symposium AFRAMED on HIV and Hepatitis September 28 to 30, Hammamet, Tunisie Following the success of the first experience in Algeria, the second edition of AFRAMED symposium will be hosted by Tunisia. This AFRAMED edition is in line...

/ 14 September 2017

IAS 2017: Closing ceremony exposes Gilead Sciences

Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered by Othoman Mellouk, during the closing...

/ 26 July 2017

HIV Activists Denounce ViiV for Denying 3.5 million People Access to Optimal Treatment

Source : ITPC GLOBAL Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment activists from around the world collectively blocked access to ViiV Healthcare’s promotional booth and stormed its...

/ 24 July 2017